Copyright
©The Author(s) 2016.
World J Transplant. Sep 24, 2016; 6(3): 573-582
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.573
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.573
Figure 3 Vasculotide treatment reduces vascular inflammation and tissue infiltration in kidney transplantation.
Fluorescent immunohistochemistry for (A) ICAM-1 (red), (B) Gr-1 (red) and (C) F4/80 (red) in kidney cross-sections of transplanted mice (vehicle or VT-treated) on day 28 after transplantation. Autofluorescence is shown in green. Images are exemplary for n = 5/condition; D: Immunoblot of murine kidney homogenate for ICAM-1 and GAPDH for the same conditions. VT: Vasculotide; ICAM-1: Intercellular adhesion molecule; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase.
- Citation: Thamm K, Njau F, Van Slyke P, Dumont DJ, Park JK, Haller H, David S. Pharmacological Tie2 activation in kidney transplantation. World J Transplant 2016; 6(3): 573-582
- URL: https://www.wjgnet.com/2220-3230/full/v6/i3/573.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i3.573